Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

cylindromatosis 1 Activators

Cylindromatosis 1 Activators, also known as CYLD activators, represent a class of molecules with a unique role in cellular regulation and signaling pathways. At their core, CYLD activators play a pivotal role in the modulation of various cellular processes, primarily through the regulation of protein ubiquitination. Ubiquitination is a post-translational modification in which small proteins called ubiquitin are attached to target proteins, often marking them for degradation or altering their activity. CYLD activators specifically target the CYLD protein, which is a deubiquitinase enzyme responsible for removing ubiquitin chains from other proteins. By enhancing the activity of CYLD, these activators effectively fine-tune the ubiquitin-dependent signaling networks within cells.

The implications of CYLD activators are profound in the context of cellular homeostasis and immunity. They are involved in the negative regulation of various pathways, such as NF-κB signaling, which is critical in immune response and inflammation. By promoting the deubiquitination of key proteins in these pathways, CYLD activators exert a downregulatory effect, helping to attenuate excessive immune responses and maintain a balanced cellular environment. Furthermore, CYLD activators have been associated with the control of cell growth, differentiation, and apoptosis, making them essential players in cellular development and survival. These molecules are a subject of extensive research, as understanding their mechanisms of action can shed light on fundamental cellular processes and may have implications in various fields of biology and disease research.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Activates SIRT1, which deacetylates and upregulates CYLD.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$37.00
$69.00
$109.00
$218.00
$239.00
$879.00
$1968.00
47
(1)

Enhances CYLD expression via NF-κB inhibition.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Induces CYLD expression through glucocorticoid receptor activation.

D,L-Sulforaphane

4478-93-7sc-207495A
sc-207495B
sc-207495C
sc-207495
sc-207495E
sc-207495D
5 mg
10 mg
25 mg
1 g
10 g
250 mg
$153.00
$292.00
$489.00
$1325.00
$8465.00
$933.00
22
(1)

Activates Nrf2, which upregulates CYLD expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Inhibits STAT3, leading to increased CYLD expression.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

HDAC inhibitor that increases CYLD gene expression.

Berberine

2086-83-1sc-507337
250 mg
$92.00
1
(0)

Activates AMPK, which enhances CYLD expression.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Inhibits NF-κB and STAT3, leading to CYLD upregulation.

Thymoquinone

490-91-5sc-215986
sc-215986A
1 g
5 g
$47.00
$133.00
21
(2)

Activates p38 MAPK, leading to increased CYLD expression.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

PPARγ agonist that upregulates CYLD gene expression.